Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo diabetes drug cuts heart risks by 13 pct in key trial
Novo diabetes drug cuts heart risks by 13 pct in key trial
Novo diabetes drug cuts heart risks by 13 pct in key trial
Submitted by
admin
on June 13, 2016 - 7:03pm
Source:
Yahoo/Reuters
News Tags:
Novo Nordisk
diabetes
Victoza
Headline:
Novo diabetes drug cuts heart risks by 13 pct in key trial
Do Not Allow Advertisers to Use My Personal information
